The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papilloma.

Abstract

PURPOSE:

To describe the use of postoperative topical mitomycin C (MMC) in the treatment of recurrent conjunctival papilloma.

METHODS:

Case report.

RESULTS:

We report a 26-year-old man with recurrent conjunctival papilloma despite repeated surgical excision, cauterization, and cryotherapy. He was then treated with excision by cryotherapy, followed by a 2-week course of topical MMC eyedrops prescribed at postoperative day 7 (0.02 mg/mL, four times daily). No recurrence was observed 24 months postoperatively, and no complication was observed during the follow-up period.

CONCLUSION:

Postoperative topical MMC may be a useful adjunct in the management of recurrent conjunctival papilloma.

• Authors: Hunter K L Yuen, Emily F Y Yeung, Nongnart R Chan, Stanley C C Chi, Dennis S C Lam
• Journal: Cornea (Cornea) Vol. 21 Issue 8 Pg. 838-9 (Nov 2002) ISSN: 0277-3740 [Print] United States
• PMID: 12410049 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antibiotics, Antineoplastic
• Ophthalmic Solutions
• Mitomycin

Topics

• Adult
• Antibiotics, Antineoplastic (administration & dosage, therapeutic use)
• Conjunctiva (drug effects, pathology)
• Conjunctival Neoplasms (drug therapy, pathology)
• Humans
• Male
• Mitomycin (administration & dosage, therapeutic use)
• Neoplasm Recurrence, Local (drug therapy)
• Ophthalmic Solutions
• Papilloma (drug therapy, pathology)
• Postoperative Period
• Treatment Outcome